Levorphanol

Composition

This formulation contain Levorphanol as active agent

Indications

It is primarily used to manage moderate to severe pain when other pain relievers such as non-opioid analgesics or weaker opioids are inadequate.

Side effects

dizziness, drowsiness, nausea, vomiting, constipation, and respiratory depression

Precautions

should be used cautiously in patients with a history of substance abuse, respiratory disorders, or hepatic or renal impairment

Contraindications

respiratory depression, acute or severe bronchial asthma, and paralytic ileus.

Dosage and administration

directed by a healthcare professional

Countries

Available Forms

Tablet, Solution

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai